The majority of individuals with high arrhythmic risk are monitored with cardiac arrhythmia monitoring equipment. These tools support medical personnel in the monitoring of irregular heartbeats for better CVD patient diagnosis and therapy to lower associated fatalities.

In 2021, the market for cardiac arrhythmia monitoring devices was USD 24.01 billion, and by 2030, it will reach USD 35.41 billion, growing at a 4.41% CAGR during the forecast period. 

The industry growth will be accelerated by the development of technologically advanced monitoring tools, like wireless monitors, that detect issues early. In recent years, the use of cardiac rhythm monitoring (CRM) devices has substantially increased due to advancements in technology and longer life expectancies. The development of CRM devices is increasing the rate of product acceptance in developed countries, which has great potential to further boost industry growth.

Market Dynamics

Drivers

The market for cardiac arrhythmia monitoring devices is expanding due to several causes, including the rising incidence of cardiovascular disorders, the development of monitoring technology, and the rising elderly population. A major element driving the market is the rising frequency of cardiovascular disorders, including heart failure. Since the danger of getting cardiovascular illnesses rises with age, the market is also driven by the expanding geriatric population.

Technological developments in monitoring equipment are also driving the development of the market. Monitoring cardiac arrhythmias is becoming more effective and efficient thanks to the development of more sophisticated and precise monitoring tools, such as wearable technology and remote monitoring systems. The availability of real-time data and alarms from these devices may enhance patient outcomes. The market development is also driven by the growing use of these devices by patients and healthcare professionals.

Restraints

The main market barriers and obstacles are:

· The high cost of the devices.

· The lack of trained employees to operate the equipment.

· The limited availability of the devices in underdeveloped nations.

Opportunity 

Governments worldwide are preparing to invest a sizeable sum of money in the technological advancements of cardiac arrhythmia monitoring devices, which can cater numerous growth opportunities for the market. This is being done because cardiovascular diseases are on the rise globally. According to the WHO, CVDs are one of the leading global causes of death.

Market Segmentation 

By Device

In 2021, the Holter monitor segment held the largest market share of nearly 25.19%. The development of wireless wearable technology for cardiac Holter monitoring is credited with the category growth. These tools can be utilized for longer periods to diagnose sporadic symptoms in ill patients. Additionally, they provide more rapid and practical monitoring to improve patient compliance and are probably to improve treatment outcomes.

By Application 

As the most prevalent arrhythmia, atrial fibrillation will rule the global market during the forecast years. It carries a high risk of blood clotting and stroke. It frequently goes misdiagnosed in clinical settings with traditional monitoring, leading to ineffective therapy when it should have been. As a result, improved diagnostic tools are needed for atrial fibrillation monitoring to get over the constraints imposed by traditional technology.

By End-User 

In 2020, hospitals held the largest market share. The size of this market is growing due to the increased rate of cardiovascular illness, the increase in cardiac implant procedures, and patient visits to hospitals for diagnostics.

Regional Analysis 

North America was the major regional market contributor. The market in the US area will grow due to the growing use of cutting-edge cardiovascular solutions and well-established healthcare infrastructure. Other factors influencing the market's expansion include the rise in cardiovascular disease incidence, rising healthcare costs, rising disposable income, and rising healthcare awareness.

The American Heart Association estimates that around 8, 36,546 Americans lose their lives to cardiovascular diseases each year, and nearly 92.1 million Americans currently have cardiovascular disease of some kind. According to the CDC's estimations, between 2.7 and 6.1 million Americans suffer from atrial fibrillation (Afib). This growing population of people is driving the market.

Key Players 

· Abbott Laboratories

· GE Healthcare

· Lepu Medical Technology

· Medtronic

· MicroPort Scientific Corp

· Boston Scientific

· Koninklijke Philips

· BioTelemetry

· Narang Medical Limited

· BPL Medical Technology

· BIOTRONIK 

· Other Players

In 2021, the market for cardiac arrhythmia monitoring devices was USD 24.01 billion, and by 2030, it will reach USD 35.41 billion, growing at a 4.41% CAGR during the forecast period. The demand for cardiac arrhythmia monitoring devices is expected to rise significantly with the rising incidence of cardiac disorders.

Related Reports:

Lung Cancer Therapeutics Market Report - The global lung cancer therapeutics market will witness a robust CAGR of 8.74%, valued at $28.56 billion in 2021, expected to appreciate and reach $60.72 billion by 2030, confirms Strategic Market Research.